Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)

NCT00662740 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium/Salmeterol QD
DRUG: Placebo
DRUG: Salmeterol
DRUG: Tiotropium/Salmeterol QD+ Salmeterol
DRUG: Tiotropium (Spiriva®)

Sponsor

Boehringer Ingelheim